š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
Goals of the study are to evaluate how peri-operative versus intra-operativ...
Status
Withdrawn
Location
Emory Clinic
Start Date
2020-05
Trial ID
NCT03920878
Treatments Being Tested
Objective: To evaluate the efficacy of intravitreal aflibercept injection o...
Status
Completed
Location
Rajavithi Hospital
Start Date
2016-12-30
Trial ID
NCT02860858
Treatments Being Tested
Although vitreous hemorrhage (VH) from proliferative diabetic retinopathy (...
Status
Completed
Location
Retinal Diagnostic Center
Start Date
2016-11
Trial ID
NCT02858076
Treatments Being Tested
This is a 12-month, prospective, randomized controlled, multi-center, open-...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-15
Trial ID
NCT07438119
The objectives of this study are to evaluate the safety and tolerability of...
Status
Completed
Location
Multiple Locations
Start Date
2015-03-12
Trial ID
NCT02397954
Treatments Being Tested
Multiple studies have implicated vascular endothelial growth factor VEGF as...
Status
Completed
Location
Arizona Retina and Vitreous Consultants
Start Date
2016-01
Trial ID
NCT02634333
Treatments Being Tested
The current application proposes to conduct a prospective, clinical trial i...
Status
Completed
Location
Medical College of Wisconsin Froedert Hospital
Start Date
2015-06
Trial ID
NCT02457975
Treatments Being Tested
The purpose of this study is to assess a new treatment pattern for afliberc...
Status
Completed
Location
Moorfields Eye Hospital NHS Foundation Trust
Start Date
2014-11
Trial ID
NCT02441816
Treatments Being Tested
The goal of this clinical trial is to understand whether ZhuochumingĀ® (Afli...
Status
Not Yet Recruiting
Location
The Third Peoples Hospital of Dalian
Start Date
2026-06-30
Trial ID
NCT07612904
Treatments Being Tested
Both aflibercept and bevacizumab have been shown to improve vision in eyes ...
Status
Completed
Location
Retinal Diagnostic Center
Start Date
2017-12-07
Trial ID
NCT03321513
Treatments Being Tested